UCH-LI expression of podocytes in diseased glomeruli and in vitro

Journal of Pathology

Volumn 217, Issue 5, 2009, Pages 642-653

  Liu, Yuan ^a,c   Wu, Jiajing ^a   Wu, Huijuan ^a   Wang, Tianzhan ^a   Gan, Hualei ^a   Zhang, Xin ^a   Liu, Ye ^a   Li, Ruixi ^b   Zhao, Zhonghua ^a   Chen, Qi ^a   Guo, Muyi ^a   Zhang, Zhigang ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Glomerulonephritis; Immunocomplex; Podocyte; Ubiquitin C terminal hydrolase L1 (UCH L1)

Indexed keywords

CYCLINE; UBIQUITIN THIOLESTERASE; UBIQUITIN THIOLESTERASE L1; UNCLASSIFIED DRUG; CYTOKINE; LYMPHOCYTE ANTIBODY; UCHL1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; COCULTURE; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IMMUNE MEDIATED INJURY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM CELL; MINIMAL CHANGE GLOMERULONEPHRITIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERUM; ANIMAL; CELL CULTURE; DRUG EFFECT; ELECTRON MICROSCOPY; GLOMERULONEPHRITIS; GLOMERULUS; METABOLISM; PATHOLOGY; ULTRASTRUCTURE;

ANIMALS; ANTILYMPHOCYTE SERUM; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; MICROSCOPY, ELECTRON; PODOCYTES; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; UBIQUITIN THIOLESTERASE;

EID: 64549144229     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2511     Document Type: Article

References (54)

1. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific protein PGP9.5 is aubiquitin carboxyl-terminal hydrolase. Science 1989;246:670-673.
2. Duncan JC. Proteolysis and the cell cycle. Cell Cycle 2002;1:233-234.
3. Hershko A, Ciechanover A, Varshavsky A. Basic Medical Research Award. The ubiquitin system. Nat Med 2000;6:1073-1081.
4. Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, Kiyo- sawa H, et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 1999;23:47-51.
5. Susor A, Ellederova Z, Jelinkova L, Halada P, Kavan D, Kubelka M, et al. Proteomic analysis of porcine oocytes during in vitro maturation reveals essential role for the ubiquitin C- terminal hydrolase-L1. Reproduction 2007;134:559-568.
6. Shirato I, Asanuma K, Takeda Y, Hayashi K, Tomino Y. Protein gene product 9.5 is selectively localized in parietal epithelial cells of Bowman's capsule in the rat kidney. J Am Soc Nephrol 2000;11:2381-2386.
7. Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson KD. Ubiquitin carboxyl-terminal hydrolase (PGP9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 1990;161:153-160.
8. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS,et al. Oxidative modifications and down-regulation of ubiq- uitin carboxyl-terminal hydrolase L1 associated with idio- pathic Parkinson's and Alzheimer's diseases. JBiol Chem 2004;279:13256-13264.
9. Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A,et al. Ubiquitin hydrolase Uch-L1 rescues β -amyloid-induced decreases in synaptic function and contextual memory. Cell 2006;126:775-788.
10. Hibi K, Westra WH, Borges M, Goodman S, Sidransky D, Jen J. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol 1999;155:711-715.
11. Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y, et al. PGP 9.5 as a marker for invasive colorectal cancer. Clin Cancer Res 2002;8:192-195.
12. Seliger B, Fedorushchenko A, Brenner W, Ackermann A, Arkins D, Hanash S, et al. Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration. Clin Cancer Res 2007;13:27-37.
13. Loeffler-Ragg J, Skvortsov S, Sarg B, Skvortsova I, Witsch- Baumgartner M, Mueller D, et al. Gefitinib-responsive EGFR- positive colorectal cancers have different proteome profiles from non-responsive cell lines. Eur J Cancer 2005;41:2338-2346.
14. Miyoshi Y, Nakayama S, Torikoshi Y, Tanaka S, Ishihara H, Taguchi T, et al. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci 2006;97:523-529.
15. Diomedi-Camassei F, Rava L, Lerut E, Callea F, Van Damme B. Protein gene product 9.5 and ubiquitin are expressed in metabolically active epithelial cells of normal and pathologic human kidney. Nephrol Dial Transpl 2005;20:2714-2719.
16. Saxen L. Organogenesis of the Kidney. Cambridge University Press: Cambridge, 1997.
17. 17.LiuY,WuH,WuJ,WangS,LiuY, ZhaoZ, et al. Detection of UCH-L1 expression by pre-embedding immunoelectron microscopy with colloidal gold labeling in diseased glomeruli. Ultrastruct Pathol 2008;32:5-9.
18. Chen G, Nagasawa R, Imasawa T, Eto Y, Kikuchi K, Maruyama N. Identification of soluble interleukin-4 receptor in rat glomerular epithelial cells. Biochim Biophys Acta 1999;1452:79-88.
19. Zhang M, Guo MY, Chen Q, Jin HM. Culture of rat mesangial cell. Acta Acad Med Shanghai [in Chinese] 1995;22:207-209.
20. Nakayama Y, Kato N, Nakajima Y, Shimizu E, Ogata Y. Effect of TNFa on human osteosarcoma cell line Saos2-TNFα regulation of bone sialoprotein gene expression in Saos2 osteoblast-like cells. Cell Biol Int 2004;28:653-660.
21. Tsukihara S, Harada T, Deura I, Mitsunari M, Yoshida S, Iwabe T, et al. Interleukin-1β-induced expression of IL-6 and production of human chorionic gonadotropin in human trophoblast cells via nuclear factor-KB activation. Am J Reprod Immunol 2004;52:218-223.
22. ChengGP, GuoMY, ZhangYE, Zhang JS, Zhang XR, Chen Q. Preparation of anti-Thy1 serum and establishment of mesangio- proliferative glomerulonephritis model in rat. J Clin Exp Pathol [in Chinese] 1996;12:241-243.
23. Tong JX,WangYW, Qiu W,Gao LJ,Xu J,WuYQ,et al. Effects of sublytic complement C5b-9 complex on the proliferation of glomerular mensangial cell associated with NF-KB activation. Acta Univ Med Nanjing (Nat Sci) [in Chinese] 2006;26:230-233.
24. Mundel P, Kriz W. Structure and function of podocytes: an update. Anat Embryol (Berl) 1995;192:385-397.
25. Shankland SJ. The podocyte's response to injury: role in protein- uria and glomerulosclerosis. Kidney Int 2006;69:2131-2147.
26. Farquhar MG, Vernier RL, Good RA. An electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus. J Exp Med 1957;106:649-660.
27. Wada T, Pippin JW, Terada Y, Shankland SJ. The cyclin- dependent kinase inhibitor p21 is required for TGFp 1-induced podocyte apoptosis. Kidney Int 2005;68:1618-1629.
28. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P,Mundel P, et al. Apoptosis in podocytes induced by TGFβ and Smad7. J Clin Invest 2001;108:807-816.
29. Chiang ML, Hawkins EP, Berry PL, Barrish J, Hill LL. Diagnostic and prognostic significance of glomerular epithelial cell vac- uolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study. Clin Nephrol 1988;30:8-14.
30. Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005;288:F48-57.
31. Kerjaschki D, Neale TJ. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol 1996;7:2518 - 2526.
32. Ebrahim H, Evans DJ. Antibody induced injury to podocytes with proteinuria and foot process swelling in a transgenic (T16) mouse. Int J Exp Pathol 1999;80:77-86.
33. Smeets B, Te Loeke NA, Dijkman HB, Steenbergen ML, Lensen JF, Begieneman MP, et al. The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol 2004;15:928-939. 34. Satoh JI, Kuroda Y. Ubiquitin C-terminal hydrolase-L1 (PGP9.5) expression in human neural cell lines following induction of neu- ronal differentiation and exposure to cytokines, neurotrophic factors or heat stress. Neuropathol Appl Neurobiol 2001;27:95-104.
34. Yamamoto T, Wilson CB. Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 1987;32:514-525.
35. Yamamoto T, Yamamoto K, Kawasaki K, Yaoita E, Shimizu F, Kihara I. Immunoelectron microscopic demonstration of Thy-1 antigen on surfaces of mesangial cells in the rat glomerulus. Nephron 1986;43:293-298.
36. Rus HG, Niculescu FI, Shin ML. Role of the C5b-9 complement complex in cell cycle and apoptosis. Immunol Rev 2001;180:49-55.
37. Akilesh S, Huber TB, Wu H, Wang G, Hartleben B, Kopp JB, et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci USA 2008;105:967-972.
38. Kazatchkine MD, Fearon DT, Appay MD, Mandet C, Bariety J. Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus. J Clin Invest 1982;69:900-912.
39. Bariéty J, Bruneval P, Hill G, Irinopoulou T, Mandet C, Meyrier A. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 2001;12:261-274.
40. Liu Y, Lashuel HA, Choi S, Xing X, Case A, Ni J, et al. Discovery of inhibitors that elucidate the role of UCH- L1 activity in the H1299 lung cancer cell line. Chem Biol 2003;10:837-846.
41. Kwon J, Mochida K, Wang YL, Sekiguchi S, Sankai T, Aoki S,et al. Ubiquitin C-terminal hydrolase L-1 is essential for the early apoptotic wave of germinal cells and for sperm quality control during spermatogenesis. Bio Reprod 2005;73:29-35.
42. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV- associated nephropathy. J Am Soc Nephrol 1999;10:51-61.
43. Srivastava T, Garola RE, Singh HK. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children. Kidney Int 2006;70:529-535.
44. Moeller MJ, Soofi A, Hartmann I, Le Hir M, Wiggins R, Kriz W, et al. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 2004;15:61-67.
45. Griffin SV, Krofft RD, Pippin JW, Shankland SJ. Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritis. Kidney Int 2005;67:977-986.
46. He JC, Husain M, Sunamoto M, D'Agati VD, Klotoman ME, Iyengar R, et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 2004;114:643-651.
47. Yu D, Petermann A, Kunter U, Rong S, Shankland S J, Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005;16:1733-1741.
48. Li JZ, Liu Y, Ji E, Huang HC, Yu F, Zou WZ, et al.The significance of urinary podocytes in patients with active lupus nephritis. Zhonghua Nei Ke Za Zhi 2007;46:127-130.
49. Petermann A, Pippin J, Hiromura K, Monkawa T, Durvasula R, Couser WG, et al. Mitotic cell cycle proteins increase in podocytes despite lack of proliferation. Kidney Int 2003;63:113-122.
50. Srivastava T, Garola RE, Whiting JM, Alon US. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood. Kidney Int 2003;63:1374-1381.
51. Srivastava T, Garola RE, Singh HK. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children. Kidney Int 2006;70:529-535.
52. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D'Agati V, Alpers CE. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int 2000;58:674-683.
53. Hiromura K, Haseley LA, Zhang P, Monkawa T, Durvasula R, Petermann AT, et al. Podocyte expression of the CDK- inhibitor p57 during development and disease. Kidney Int 2001;60:2235-2246.
54. Caballero OL, Resto V, Patturajan M, Meerzaman D, Guo MZ, Engles J, et al. Interaction and colocalization of PGP 9.5 with JAB1 and p27 (Kip1). Oncogene 2002;21:3003-3010.